A human pluripotent stem cell-derived in vitro model of the blood–brain barrier in cerebral malaria
DOI: 10.1186/s12987-024-00541-9
Authors: Adnan Gopinadhan; Jason M. Hughes; Andrea L. Conroy; Chandy C. John; Scott G. Canfield; Dibyadyuti Datta
Step 1: iPSC/ESC maintainance
day 0 ~ 3
culture “adherent” human PSC in “mTeSR” for “3” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should be changed once in “3” days.
Ideally, “PSC” should be obtained at the end of culture.
Step 2: Primitive streak 1
day 3 ~ 4
culture “adherent” human PSC in “DMEM/F12” for “1” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “1” days.
| concentration | unit | |
|---|---|---|
| 2-mercaptoethanol | 1.0e-4 | mol/l |
| NEAA | — | — |
Step 3: endothelial 1
day 4 ~ 6
culture “adherent” human PSC in “Endothelial Serum-Free Medium” for “2” days. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table, and should be changed once in “2” days.
| concentration | unit | |
|---|---|---|
| FGF | 2.0e-5 | g/l |
| PDS | 1 | % |
| retinoic acid | 0.01 | mol/l |
Ideally, “EC” should be obtained at the end of culture.
Step 4: endothelial 2
day 6 ~ 7 (duration missing in database; assumed 1 day)
culture “adherent” human PSC in “Endothelial Serum-Free Medium”. For ECM, use “Matrigel” at “N/A” “N/A”. Medium should contain factors shown in the following table.
| concentration | unit | |
|---|---|---|
| PDS | 1 | % |
Ideally, “EC” should be obtained at the end of culture.